Introduction
The study of viral hepatitis in man is seriously limited by the long-standing difficulties in isolating the etiologic agent in vitro and in reproducing the disease in animals. Canine hepatitis, however, is a viral disease of the liver which produces striking hepatic damage in dogs and which has the experimental advantage of being caused by a cultivatable adenovirus. Viral hepatitis is widespread in the canine population and is a common cause of death. The disease was originally described in 1947 by Rubarth (1) , who established the viral etiology and demonstrated the pathologic findings in dogs dying of the disease. In 1954 Cabasso and his coworkers (2) reported the successful propagation of the canine hepatitis virus in vitro. This led to attenuation of the virus in tissue culture and made possible the development of an effective live virus vaccine (3) (4) (5) . Subsequent investigation has shown the canine hepatitis virus to be an adenovirus which has partial antigenic cross-reactivity with human adenoviruses, but which is not known to produce disease in man (6, 7) . Current knowledge concerning this virus has been reviewed by Cabasso (8) .
The ability to isolate and grow the causative agent of canine hepatitis in vitro makes it possible to carry out the type of controlled experiment in the dog which cannot be done at the present time in man. Thus, the canine disease has been employed in this laboratory as a convenient model for the experimental study of viral infection of the liver, and the correlation of pathologic and virologic events with alterations in hepatic function. In the course of this study, it became apparent that the pattern of response to experimental infection was distinctly modified by the immune status of the animal. More specifically, a syndrome of chronic progressive hepatic damage has been observed in dogs which were only partially immune to the virus. In addition, it has been possible to reproduce such chronic liver disease in susceptible dogs by passive immunization to the canine hepatitis virus. These observations are the subject of this report.
Methods
The animals used in these studies were young purebred beagles, 12-20 wk old, obtained from the Cyn-Piera Kennels.' The dogs were born and raised in an isolated environment in order to avoid natural infection with canine hepatitis virus. Approximately 1 month before study, they were immunized against distemper with an attenuated live virus vaccine (Tissuevax, Pitman-Moore Co., Indianapolis, Ind.), and against leptospirosis with a standard heat-killed Leptospiral antigen (Leptospira Bacterin, Pitman-Moore). The animals were transported by air to this laboratory, subjected to control studies, and then infected within 12 hr after removal from isolation.
The following studies were carried out before infection, daily during the early acute phase, and then less frequently during the latter phases. The Primary cultures of canine kidney were prepared by the method of Bodian (10), or obtained from commercial sources.2 The growth medium was the minimum essential medium of Eagle (Microbiological Associates, Inc.) supplemented with 10% fetal calf serum (Grand Island Biological Co., Grand Island, N. Y.) heated at 560C for 30 min, penicillin 100 ,ug/ml, and streptomycin 100 gg/ml. For maintenance, the serum concentration was reduced to 1%. Virus titrations were carried out by the tube technique under the conditions recommended for this system by Carmichael et al. (11) . Titers were expressed in TCIDso as determined by the Karber method (12) . Neutralizing antibody to the canine hepatitis virus in serum was determined in a standard tissue culture neutralization assay, with 100 TCID5o of the virus as the test dose. Results were expressed in terms of the dilution of serum giving 50%o neutralization of the cytopathic effect.
Fluorescent antibody techniques. Sera containing high titers of neutralizing antibody were conjugated with fluorescein diisothiocyanate by the method of Rinderknecht (13) . To minimize nonspecific staining, we passed the conjugated antisera through a 10 X 2 cm column of G25 Sephadex, and absorbed them 4 times with 10 mg of acetone-dried liver powder per ml of serum. Needle biopsy specimens of the liver were rapidly frozen on dry ice. Sections were cut at 3 A in an International microtome cryostat and fixed in acetone for 15 min, and fluorescein-conjugated antiserum was applied for 60 min at 37°C in a humid chamber. The specimens were washed 3 times with phosphate-buffered saline (pH 7.2), and examined microscopically for specific fluorescence using ultraviolet illumination and the darkfield technique. Specificity of the fluorescence for canine hepatitis virus was established by the following control procedures: (a) pretreatment of frozen sections of infected liver with unconjugated antiserum (followed by fluorescein-conju- 105 'F, and hepatic dysfunction was first evident in depression of BSP Tm (70%o of control). By the 6th day, the animal was noticeably lethargic and anorectic, the SGOT was now definitely elevated (95 Karmen units), and both BSP S and Tm were reduced (80 and 65% of control, respectively). Thereafter, the disease process seemed to explode, and within 12 hr the dog expired before further studies could be carried out. Neutralizing antiviral antibody was not found in detectable amounts (< a) before or during the illness.
The earliest abnormality recognized in the liver of this dog was found on day 5 at the time when viremia was first detected. A diffuse increase in inflammatory cells in the hepatic sinusoids and the appearance of characteristic intranuclear inclusion bodies of the canine hepatitis virus, predominantly in Kupffer cells, were observed ( Fig.  1 a) . The presence of viral antigen in these cells was demonstrated in frozen sections of the liver stained with fluorescein-labeled antiviral antibody ( Fig. 1 b) . By day 6, the liver was studded with small foci of parenchymal necrosis containing typical intranuclear inclusion bodies (Fig. 2 a) . Small clusters of viral material were seen in these foci on staining with fluorescent antibody (Fig.  2 b) . Finally, when examined at autopsy 12 hr later, severe hepatic necrosis ( The disease pattern observed in all 19 of the acute animals was similar to that described above for Lydia. (Table II) in which blood was obtained only 2-3 hr before death had marked elevations of SGOT and alkaline phosphatase. Measurement of other clinical and chemical parameters commonly employed in the study of human liver disease were not found to be useful because the fulminant course did not allow significant changes to be observed. Significant elevation of serum bilirubin was rarely observed because of the high renal clearance of bile pigments in the dog.
It was possible to carry out detailed studies of BSP kinetics during the course of acute hepatitis in 11 puppies. Each animal served as its own control. Control values for S ranged from 10.8 to 14 mg/mg% (averaged 12.8, SD 1.18), and for Tm from 2.4 to 3.2 mg/min (average 2.9, SD 0.26). After infection, a depression in one or both values was observed as early as day 2 in two animals. By the 4th day after infection, both S and Tm were usually decreased (average 65% of control) in the nine animals studied at that time. Elevations in the SGOT and serum alkaline phosphatase were always associated with changes in BSP kinetics, and in two animals a depression of Tm and S preceded enzymatic abnormalities.
It is emphasized that none of the dogs with acute disease had detectable antibody to the virus at the time of infection nor did they develop antibody during the brief course of their illness. These animals appeared to have been fully susceptible and were overwhelmed by the virus before an immune response could occur. Hepatic biopsies on the 5th day after infection revealed small foci of necrosis similar to that shown in Fig. 2 . Virus was identified in these lesions by the presence of intranuclear inclusion bodies, and by specific staining with fluoresceinlabeled antiviral antibody. In addition to the usual polymorphonuclear leukocyte response, the necrotic foci contained significant numbers of lymphocytes and plasma cells. The sections in Fig. 4 ?2) Chronic disease. Chronic hepatic damage was observed in seven dogs with low antibody titers who survived as long as 8 months after infection. Initially, there was minimal clinical or biochemical evidence of illness in these animals. However, biopsies during the 1st wk after infection revealed small foci of hepatic necrosis with inclusion bodies and positive fluorescent staining indistinguishable from that seen in acute animals (Fig. 2) . The animals survived this early phase and over the following months the evolution of chronic hepatic damage was observed. Fig. 5 a is from the 27th day after infection in the dog Tally and shows one of the dense accumulations of lymphoid cells and plasma cells scattered throughout the liver. Fig. 5 b was obtained 2 months after infection in this dog and shows an enlarged portal area infiltrated with round cells and plasma cells. 5 months after infection chronic inflammatory infiltrates persisted and portal fibrosis was noted. Tally expired 7 months after infection, and at autopsy marked chronic inflammation and significant fibrosis were found (Fig. 6) . Beyond the 10th day after infection, virus was no longer iden- 
II) EXPERIMENTAL MODIFICATION OF THE DIS-

EASE
The observations described above on the occurrence of the subacute and chronic forms of hepatic disease after experimental infection were initially the results of chance encounters with partially immune dogs. When the apparent relation between low titers of antibody to the virus and prolonged forms of hepatitis was recognized, experiments were undertaken to reproduce and confirm these findings in a prospective fashion. This was done by passive administration of hyperimmune antiserum against the canine hepatitis virus to fully susceptible dogs. On the basis of the estimated blood volume of the dog and the titer of the antiserum, the amount of serum required to produce approximately a 1/0 titer of antibody in the animal was calculated. The antiserum was administered intravenously, and 10-20 min later the animal was infected with the standard dose of virus. In the first eight attempts, the subacute disease pattern has been observed in three dogs and the chronic pattern has occurred in four, one of which died at 4 months. The remaining dog died on day 5 with typical acute hepatitis. In addition, a control group of five fully susceptible dogs not given antiserum was inoculated in the same manner with the same dose and preparation of virus, and all went on to die with typical actue hepatitis. The hepatic changes seen in the passively immunized animals duplicated the histologic findings already described. Thus, the subacute and chronic disease patterns observed in dogs passively immunized to the hepatitis virus before infection were indistinguishable from the patterns encountered in animals with partial natural immunity.
Discussion
The acute form of canine hepatitis observed in these studies was a fulminant, rapidly fatal infection in animals lacking an effective immune defense. The virus was first found in the Kupffer cells of the liver, suggesting that the infectious agent reached the liver by the blood stream, and was filtered out by cells of the reticuloendothelial system. Once in the Kupffer cells, the virus underwent rapid multiplication, with an explosive progression of hepatic damage. In contrast to the situation in the subacute and chronic diseases to be discussed below, there was an easily recognized correlation between the demonstrable presence of virus and the extent of hepatic necrosis. The degree of functional abnormalities correlated well in general with the severity of hepatic necrosis. The pathophysiologic factors responsible for death in these animals have not been well studied previously and are a subject of continuing investigation. However, it has been extensively shown by Rubarth (1) and others, and confirmed in our experience, that although the virus can be found throughout the body, the liver is the only site of major injury.
None of the 19 animals that succumbed to the fulminating acute form of hepatitis (Group A) had detectable antibody to the canine hepatitis virus in the serum either at the time of infection or during the brief illness. The absence of neutralizing antibody was quite consistent with rapid progression of the infection and death of the animal before an effective immune defense could be raised. At the other extreme, the dogs that failed to develop any sign of illness (Group C) were always found to have relatively high levels of neutralizing antibody to the virus in the serum at the time of infection. No exception to these observations has been encountered and, indeed, this would be the expected effect of specific immunity to an infectious agent on the outcome of the infection.
The animals in Group B, however, demonstrate an unexpected and untoward effect of host immunity on the course of the disease. These dogs had low titers of antiviral antibody at the time of infection, or were able to produce antibody rapidly in the first 4-6 days of illness. They survived the initial phase but developed definite hepatic damage, sometimes leading to death, despite the presence of antibody to the infectious agent. Thus, partial immunity to the virus seemed to have a clear, though unexplained, correlation with the development of persistent hepatic injury. This observation was strongly supported by the successful reproduction of the subacute and chronic forms of hepatitis in seven of the eight dogs passively immunized to the virus.
Certain notable features characterize the subacute and chronic disease patterns. Although the ICH virus could be identified in small necrotic foci in the liver in the first few days after infection, the rapid progression of hepatic necrosis seen in the acute disease did not occur. Instead, the virus seemed to disappear, at least in so far as it could be detected by the techniques available. In contrast to Group A animals, the virus could not be found in the animals even when severe hepatic necrosis and death occurred. Whether the disappearance of the virus is real or only apparent is not yet clear. The absence of intranuclear inclusion bodies and the negative fluorescent antibody test do not completely rule out the persistence of virus in an incomplete or atypical form. Attempts have been made to recover virus from the liver in tissue culture on 41 different occasions in nine dogs with positive results only in the 1st wk after infection. Additional recovery attempts are currently underway to extend these findings.
Despite the apparent absence of the virus, hepatic damage continued in both the subacute and chronic animals. The predominance of lymphoid elements was an outstanding feature. In the subacute disease, severe and extensive hepatic necrosis ensued, leading to death of the animal. The hepatic damage involved the entire liver lobule, and lymphocytes, monocytes, and plasma cells were scattered profusely in the sinusoids and in dense accumulations about central veins and in portal tracts. In the chronic disease, the animals survived at least for several months with evidence of persistent hepatic injury. In the early weeks focal collections of lymphoid cells were found throughout the liver, and in later stages these chronic inflammatory cells were localized in portal areas in association with fibrosis. The finding of portal fibrosis in the later stages of the chronic disease is of note. In some instances, fibrosis was quite definite and had interlobular extensions. However, severe distortion of hepatic architecture and lobular regeneration were not prominent findings, nor was evidence of portal hypertension available. What is noteworthy is the finding of a chronic, prolonged form of hepatic damage with portal fibrosis as one of the outstanding features.
The source of the antiviral antibody in the animals with partial immunity is of some interest. Carmichael et al. (14) found the half-life of maternal neutralizing antibody to the ICH virus in young beagle puppies was 8.6 days. Thus, the age of the animals used in this study ( 12-20 wk) should have allowed for the disappearance of the bulk of maternal antibody. However, it is conceivable that occasional puppies were encountered from sufficiently high titered mothers to provide for the persistence of low titers of antiviral antibody in the offspring even at 5 months of age. Unfortunately, maternal serum was not available for titration. Also, it is possible that some of the animals had previous unrecognized natural infections. Perhaps the dogs that lacked antibody initially, but developed titers rapidly, were showing an anamnestic response. Another possible source of low levels of antibody may lie in the known antigenic relationship of the ICH adenovirus to some of the human adenoviruses. Carmichael and Baker (15) have made the interesting observation that dogs inoculated intranasally with adenovirus type 4 developed neutralizing antibodies following an asymptomatic infection. When such dogs were later inoculated with ICH virus, a secondary or anamnestic type of neutralizing antibody response occurred to both viral antigens, and antibodies persisted for at least 340 days. Thus, it is conceivable that our animals had been previously exposed to a human adenovirus while in isolation and thus sensitized to subsequent inoculation with ICH virus. The presence of small amounts of antibody to the virus may simply permit the animal to survive the acute stages of infection, and then some other pathologic process supervenes to produce further hepatic injury. However, it is not at all clear why a small amount of antibody should not simply suppress or attenuate the infection with eventual recovery, rather than predispose to continuing liver damage.
Although there is ample precedent for the persistence of virus in a host's tissues with production of latent or inapparent infection, in such instances the virus is demonstrable at sites of cell damage (16) (17) (18) . Also, virus can be identified easily in the liver in other types of viral hepatitis (18) (19) (20) 
